PTK2 and breast cancer: Similarly, protein tyrosine kinase 2 (PTK2) (which indicates oncogenic transformation) could also be tracked in MVs derived from MDAMB231 cells, further suggesting that analysis of EV content is an attractive target for diagnostics in breast cancer (132).